Terlipressin or oxytocin during open fibroid surgery
Treatments studied
Part of Cancer clinical trials.
This trial compares two injected medicines (terlipressin vs carbetocin) given into the uterus during open fibroid (myomectomy) surgery to see which one reduces blood loss and helps maintain hemoglobin. It may help patients by targeting lower bleeding during surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 16 to 45.
- You are having an open myomectomy for fibroids, with the biggest fibroid between 4 cm and 20 cm.
- Your starting blood count (hemoglobin) is at least 9 g/dl.
- You are able to be given either terlipressin or carbetocin (no medical reasons you cannot).
- You are not pregnant right now (negative urine pregnancy test or last period within 4 weeks).
- You have not had fibroid surgery before, and you are not on blood thinners (anticoagulants).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different medications given as shots during laparoscopic fibroid (myomectomy) surgery. The goal is to see which shot better reduces blood loss and helps keep hemoglobin (a blood oxygen-carrying protein) from dropping too much.
This study tests if blocking blood flow to the uterus and ovaries during minimally invasive fibroid removal surgery helps reduce bleeding. It may be an option if you are having this type of surgery for large or numerous fibroids.
This trial looks at ways to prevent scar tissue (intra-uterine adhesions) from forming after fibroid removal surgery. If you are having myomectomy, you may be helping test an approach that could protect the inside of your uterus.
This trial compares two medications (ergometrine and carbetocin) given during surgery to see which one is better at reducing bleeding while removing fibroids. Both drugs help the uterus contract to control blood loss.
This trial compares two surgical techniques to reduce bleeding during surgery to remove fibroids (benign tumors) from the uterus. The goal is to find the safest, least-bloody approach for women who need this procedure.
This trial tests whether temporarily clamping the main blood vessels to the uterus during laparoscopic fibroid removal can reduce blood loss. It is for women with up to four fibroids who are planning this type of surgery.
Hear when a new Myoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.